• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚类分析确定多囊卵巢综合征女性不同表型特征的亚型。

Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome.

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus MC, Erasmus University Medical Center, 3015 GD, Rotterdam, the Netherlands.

Department of Internal Medicine, Erasmus MC, Erasmus University Medical Center, 3015 GD, Rotterdam, the Netherlands.

出版信息

J Clin Endocrinol Metab. 2024 Nov 18;109(12):3096-3107. doi: 10.1210/clinem/dgae298.

DOI:10.1210/clinem/dgae298
PMID:38753423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11570376/
Abstract

CONTEXT

Hierarchical clustering (HC) identifies subtypes of polycystic ovary syndrome (PCOS).

OBJECTIVE

This work aimed to identify clinically significant subtypes in a PCOS cohort diagnosed with the Rotterdam criteria and to further characterize the distinct subtypes.

METHODS

Clustering was performed using the variables body mass index (BMI), luteinizing hormone (LH), follicle-stimulating hormone, dehydroepiandrosterone sulfate, sex hormone-binding globulin (SHBG), testosterone, insulin, and glucose. Subtype characterization was performed by analyzing the variables estradiol, androstenedione, dehydroepiandrosterone, cortisol, anti-Müllerian hormone (AMH), total follicle count (TFC), lipid profile, and blood pressure. Study participants were girls and women who attended our university hospital for reproductive endocrinology screening between February 1993 and February 2021. In total, 2502 female participants of European ancestry, aged 13 to 45 years with PCOS (according to the Rotterdam criteria), were included. A subset of these (n = 1067) fulfilled the National Institutes of Health criteria (ovulatory dysfunction and hyperandrogenism). Main outcome measures included the identification of distinct PCOS subtypes using cluster analysis. Additional clinical variables associated with these subtypes were assessed.

RESULTS

Metabolic, reproductive, and background PCOS subtypes were identified. In addition to high LH and SHBG levels, the reproductive subtype had the highest TFC and levels of AMH (all P < .001). In addition to high BMI and insulin levels, the metabolic subtype had higher low-density lipoprotein levels and higher systolic and diastolic blood pressure (all P < .001). The background subtype had lower androstenedione levels and features of the other 2 subtypes.

CONCLUSION

Reproductive and metabolic traits not used for subtyping differed significantly in the subtypes. These findings suggest that the subtypes capture distinct PCOS causal pathways.

摘要

背景

层次聚类(HC)可识别多囊卵巢综合征(PCOS)的亚型。

目的

本研究旨在根据鹿特丹标准诊断为 PCOS 的患者队列中识别具有临床意义的亚型,并进一步描述不同的亚型。

方法

使用体重指数(BMI)、促黄体生成激素(LH)、卵泡刺激素、硫酸脱氢表雄酮、性激素结合球蛋白(SHBG)、睾酮、胰岛素和血糖等变量进行聚类。通过分析雌二醇、雄烯二酮、脱氢表雄酮、皮质醇、抗苗勒管激素(AMH)、总卵泡计数(TFC)、血脂谱和血压等变量来描述亚型特征。研究参与者为 1993 年 2 月至 2021 年 2 月期间到我们大学医院进行生殖内分泌筛查的女孩和女性。共纳入 2502 名欧洲裔 PCOS 女性患者(根据鹿特丹标准),年龄 13 至 45 岁。其中一部分(n=1067)符合美国国立卫生研究院标准(排卵功能障碍和高雄激素血症)。主要观察指标包括使用聚类分析确定不同的 PCOS 亚型。评估与这些亚型相关的其他临床变量。

结果

确定了代谢、生殖和背景 PCOS 亚型。除了高 LH 和 SHBG 水平外,生殖亚型的 TFC 和 AMH 水平最高(均 P<.001)。除了高 BMI 和胰岛素水平外,代谢亚型的低密度脂蛋白水平更高,收缩压和舒张压也更高(均 P<.001)。背景亚型的雄烯二酮水平较低,且具有其他 2 种亚型的特征。

结论

用于分型的生殖和代谢特征在各亚型中差异显著。这些发现表明,这些亚型可以捕获不同的 PCOS 因果途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/11570376/f6009f6875e1/dgae298f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/11570376/f8052c82045b/dgae298f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/11570376/f6009f6875e1/dgae298f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/11570376/f8052c82045b/dgae298f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d374/11570376/f6009f6875e1/dgae298f2.jpg

相似文献

1
Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome.聚类分析确定多囊卵巢综合征女性不同表型特征的亚型。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3096-3107. doi: 10.1210/clinem/dgae298.
2
AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.抗缪勒管激素联合性激素结合球蛋白用于多囊卵巢综合征的诊断。
J Obstet Gynaecol. 2019 Nov;39(8):1130-1136. doi: 10.1080/01443615.2019.1587604. Epub 2019 Jun 17.
3
Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.抗苗勒管激素和抑制素A,而非抑制素B或胰岛素样肽3,可作为青少年多囊卵巢综合征诊断的替代指标:初步结果
J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):288-97. doi: 10.4274/jcrpe.3253. Epub 2016 Apr 29.
4
Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.激素谱分析,包括抗苗勒管激素(AMH),用于多囊卵巢综合征(PCOS)的诊断和 PCOS 表型的特征描述。
Gynecol Endocrinol. 2019 Jul;35(7):595-600. doi: 10.1080/09513590.2018.1559807. Epub 2019 Jan 22.
5
[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[多囊卵巢综合征女性与育龄期健康女性的血清抗苗勒管激素水平]
Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23.
6
Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.具有新型遗传关联的多囊卵巢综合征的不同亚型:一种无监督的、表型聚类分析。
PLoS Med. 2020 Jun 23;17(6):e1003132. doi: 10.1371/journal.pmed.1003132. eCollection 2020 Jun.
7
Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.多囊卵巢综合征患者女儿在不同 Tanner 期的抗苗勒管激素(AMH)与胰岛素水平的关系。
Reprod Sci. 2012 Apr;19(4):383-90. doi: 10.1177/1933719111424444. Epub 2012 Feb 16.
8
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.多囊卵巢综合征和肥胖对绝经前女性血清促性腺激素和性激素浓度的独立影响。
Clin Endocrinol (Oxf). 1994 Oct;41(4):473-81. doi: 10.1111/j.1365-2265.1994.tb02578.x.
9
Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.瘦女性抗苗勒管激素水平升高可能并不意味着患有多囊卵巢综合征。
Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):552-557. doi: 10.1111/ajo.12647. Epub 2017 Jun 9.
10
The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.高雄激素血症多囊卵巢综合征患者的性激素结合球蛋白、总睾酮、雄烯二酮和游离睾酮与代谢和生殖特征的关系。
Endocrinol Diabetes Metab. 2021 May 24;4(3):e00267. doi: 10.1002/edm2.267. eCollection 2021 Jul.

引用本文的文献

1
Artificial intelligence in polycystic ovarian syndrome management: past, present, and future.人工智能在多囊卵巢综合征管理中的应用:过去、现在与未来
Radiol Med. 2025 Jun 23. doi: 10.1007/s11547-025-02032-9.
2
The Role of Gene Alterations in the Pathogenesis of Polycystic Ovary Syndrome.基因改变在多囊卵巢综合征发病机制中的作用
J Clin Med. 2025 May 12;14(10):3347. doi: 10.3390/jcm14103347.
3
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: The significance of functional adrenal hyperandrogenism in polycystic ovary syndrome across the lifespan.

本文引用的文献

1
Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study.不同多囊卵巢综合征亚型中体脂和骨骼肌质量与心血管代谢风险的关联各异:一项倾向评分匹配的病例对照研究
J Clin Med. 2024 Jan 15;13(2):483. doi: 10.3390/jcm13020483.
2
Distinct Reproductive Phenotypes Segregate With Differences in Body Weight in Adolescent Polycystic Ovary Syndrome.不同的生殖表型与青少年多囊卵巢综合征体重差异相关。
J Endocr Soc. 2024 Jan 9;8(2):bvad169. doi: 10.1210/jendso/bvad169. eCollection 2024 Jan 5.
3
Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci.
多囊卵巢综合征:起源与影响:功能性肾上腺雄激素过多症在整个生命周期的多囊卵巢综合征中的意义。
Reproduction. 2025 May 30;169(6). doi: 10.1530/REP-25-0091. Print 2025 Jun 1.
4
Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome.多囊卵巢综合征中生殖功能障碍与代谢功能障碍之间的关联
Curr Opin Obstet Gynecol. 2025 Apr 29. doi: 10.1097/GCO.0000000000001037.
5
Regulatory risk loci link disrupted androgen response to pathophysiology of Polycystic Ovary Syndrome.调控风险位点将雄激素反应紊乱与多囊卵巢综合征的病理生理学联系起来。
medRxiv. 2025 Mar 27:2025.03.26.25324630. doi: 10.1101/2025.03.26.25324630.
6
Advances in cardiometabolic outcomes in polycystic ovary syndrome.多囊卵巢综合征中心血管代谢结局的进展
Nat Rev Endocrinol. 2025 Feb;21(2):67-68. doi: 10.1038/s41574-024-01072-x.
7
SmartScanPCOS: A feature-driven approach to cutting-edge prediction of Polycystic Ovary Syndrome using Machine Learning and Explainable Artificial Intelligence.智能扫描多囊卵巢综合征:一种使用机器学习和可解释人工智能对多囊卵巢综合征进行前沿预测的特征驱动方法。
Heliyon. 2024 Oct 11;10(20):e39205. doi: 10.1016/j.heliyon.2024.e39205. eCollection 2024 Oct 30.
多囊卵巢综合征通过遗传位点聚类所涉及的生理途径。
J Clin Endocrinol Metab. 2024 Mar 15;109(4):968-977. doi: 10.1210/clinem/dgad664.
4
Cluster analysis reveals a homogeneous subgroup of PCOS women with metabolic disturbance associated with adverse reproductive outcomes.聚类分析揭示了多囊卵巢综合征(PCOS)女性中存在一个与不良生殖结局相关的代谢紊乱同质亚组。
Chin Med J (Engl). 2024 Mar 5;137(5):604-612. doi: 10.1097/CM9.0000000000002787. Epub 2023 Aug 24.
5
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463.
6
Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study.多囊卵巢综合征患者无论采用何种诊断标准,其心血管疾病风险均增加——一项前瞻性基于人群的队列研究。
Eur J Endocrinol. 2023 Jul 20;189(1):96-105. doi: 10.1093/ejendo/lvad077.
7
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification.解构综合征:多囊卵巢综合征发病机制和分类的基因组学见解。
Endocr Rev. 2022 Nov 25;43(6):927-965. doi: 10.1210/endrev/bnac001.
8
Polycystic Ovary Syndrome Susceptibility Loci Inform Disease Etiological Heterogeneity.多囊卵巢综合征易感基因座揭示疾病病因异质性。
J Clin Med. 2021 Jun 18;10(12):2688. doi: 10.3390/jcm10122688.
9
Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis.具有新型遗传关联的多囊卵巢综合征的不同亚型:一种无监督的、表型聚类分析。
PLoS Med. 2020 Jun 23;17(6):e1003132. doi: 10.1371/journal.pmed.1003132. eCollection 2020 Jun.
10
The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.中年多囊卵巢综合征女性的心血管风险特征。
Clin Endocrinol (Oxf). 2020 Feb;92(2):150-158. doi: 10.1111/cen.14117. Epub 2019 Nov 24.